Rhythm Pharmaceuticals, Inc. - Special Call Transcript
Good morning. I'm Hunter Smith, Chief Financial Officer of Rhythm Pharmaceuticals, and I want to thank you for joining us as we discuss our proof-of-concept data from the exploratory Phase II Basket Study and provide an update on our sequencing efforts.
Please note the press release issued earlier today and presentation we're using for this conference call are both available online in the Investors and Media section of our website: rhythmtx.com. Before we begin, I'd like to remind everyone that there will be forward-looking statements made on this call. Actual events or results could differ materially from those expressed or implied by any forward-looking statements, such as a result of various risks, uncertainties and other factors, including those set forth in the Risk Factors section of our Forms 10-K or 10-Q or any other filings that we make with the SEC in the future. In addition, any forward-looking statements made on this call represent our views only as of today and should not be relied upon as representing our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
